Dr. Mark Christian Domanski, MD

Dr. Domanski practices at Inova Alexandria Hospital in Alexandria, Virginia, part of Inova Health Care Services.

Dr. Domanski's NPI, 1992993885, was assigned on October 4, 2007. Dr. Domanski graduated from University of Maryland School of Medicine - Baltimore in 2006. Dr. Domanski holds Virginia license 0101257764.

Dr. Domanski's primary practice is Inova Alexandria Hospital, at 4320 Seminary Rd, Alexandria, VA 22304 in Alexandria City. The practice phone is (703) 504-3167.

Dr. Domanski's primary practice is Inova Alexandria Hospital in Alexandria, Virginia, part of Inova Health Care Services. Dr. Domanski is also affiliated with Inova Fairfax Hospital. Dmand AI also links Dr. Domanski to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Domanski practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Domanski's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Domanski is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Domanski's licenses on file in 5 states: Virginia, Louisiana, Mississippi, Maryland and District of Columbia.

Dmand AI lists head wound and removal of damaged skin or skin graft among the conditions Dr. Domanski treats.

CMS data shows 83 Medicare services from Dr. Domanski across 3 procedure codes in 2024, for 89 Medicare patients. Medicare paid $8,654 for them.

CMS counts 89 Medicare patients who saw Dr. Domanski in 2024. The largest group is 75 to 84, with 39 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Domanski's median patient age at 54, with 69% women.

In 2024, Dr. Domanski wrote 71 Medicare Part D claims for 17 patients. 94% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $151 in total drug cost.

Dr. Domanski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Domanski, published from 2011 to 2013. 2012 was the busiest year, with 3. The most frequent topics are Endoscopy and Otolaryngology. Dr. Domanski has published most often in F1000Res. Dr. Domanski's most frequent co-authors are Paul C. Frake, MD, Louis Choong Lee, MD and Houtan Chaboki, MD.

CMS Open Payments shows 12 general payments to Dr. Domanski from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Integra LifeSciences Corporation paid the most, $280.

Dmand AI lists 2 awards for Dr. Domanski, most recently Top Doctors in 2023.

Dr. Domanski graduated from University of Maryland School of Medicine - Baltimore in 2006. Dr. Domanski is a member of ASPS.

Dr. Domanski is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.